Scleroderma Research Foundation
EIN: 680087234 · San Francisco, CA · NTEE: H46Z
| Metric | Value |
|---|---|
| Total Revenue | $12.4M |
| Total Expenses | $6.5M |
| Net Assets | $11.5M |
Is Scleroderma Research Foundation Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Scleroderma Research Foundation
Scleroderma Research Foundation (EIN: 680087234) is a nonprofit organization based in San Francisco, CA, classified under NTEE code H46Z. The organization reported total revenue of $12.4M and total assets of $33.0M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Scleroderma Research Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Scleroderma Research Foundation is a large nonprofit that has been operating for 39 years, with 13 years of IRS 990 filings on record (2012–2023). Revenue has grown at a compound annual rate of 18.8%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $8.4M |
| Total Expenses | $6.5M |
| Surplus / Deficit | +$1.9M |
| Total Assets | $18.7M |
| Total Liabilities | $7.1M |
| Net Assets | $11.5M |
| Operating Margin | 22.9% |
| Debt-to-Asset Ratio | 38.2% |
| Months of Reserves | 34.5 months |
Financial Health Grade: A
In 2023, Scleroderma Research Foundation reported a surplus of $1.9M with revenue exceeding expenses, holds 34.5 months of operating reserves (strong position), has a debt-to-asset ratio of 38.2% (moderate leverage).
Financial Trends
Over 13 years of filings (2012–2023), Scleroderma Research Foundation's revenue has grown at a compound annual growth rate (CAGR) of 18.8%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +42.9% | +39.3% | +67.4% |
| 2022 | +56.3% | +26.3% | +13.5% |
| 2021 | -4.1% | +24.7% | +2.4% |
| 2020 | +41.8% | +179.4% | -0.6% |
| 2019 | -46.4% | -68.5% | +29.6% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1987 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Scleroderma Research Foundation has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Scleroderma Research Foundation with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $1.9M, with revenue exceeding expenses.
- Debt-to-asset ratio: 38.2%.
Frequently Asked Questions about Scleroderma Research Foundation
Is Scleroderma Research Foundation a legitimate charity?
Scleroderma Research Foundation (EIN: 680087234) is a registered tax-exempt nonprofit based in California. It has 13 years of IRS 990 filings on record. Total revenue: $12.4M. No red flags identified. Financial health grade: A.
How does Scleroderma Research Foundation spend its money?
Scleroderma Research Foundation reported $12.4M in total revenue in IRS 990 filings. 13 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Scleroderma Research Foundation tax-deductible?
Scleroderma Research Foundation is registered as a tax-exempt nonprofit (EIN: 680087234). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Scleroderma Research Foundation located?
Scleroderma Research Foundation is headquartered in San Francisco, California and files with the IRS under EIN 680087234. It is classified under NTEE code H46Z.
How many years of IRS 990 filings does Scleroderma Research Foundation have?
Scleroderma Research Foundation has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $12.4M in total revenue.
Filing History
IRS 990 filing history for Scleroderma Research Foundation showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2012–2023), Scleroderma Research Foundation's revenue has grown by 564.5%, moving from $1.3M to $8.4M. Total assets increased by 531.6% over the same period, from $3.0M to $18.7M. Total functional expenses rose by 279.2%, from $1.7M to $6.5M. In its most recent filing year (2023), Scleroderma Research Foundation reported a surplus of $1.9M, with revenue exceeding expenses. The organization holds $7.1M in liabilities against $18.7M in assets (debt-to-asset ratio: 38.2%), resulting in net assets of $11.5M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $8.4M | $6.5M | $18.7M | $7.1M | — | — |
| 2022 | $5.9M | $4.7M | $11.1M | $1.2M | — | — |
| 2021 | $3.8M | $3.7M | $9.8M | $347K | — | View 990 |
| 2020 | $3.9M | $3.0M | $9.6M | $201K | — | — |
| 2019 | $2.8M | $1.1M | $9.6M | $587K | — | View 990 |
| 2019 | $5.2M | $3.4M | $7.4M | $297K | — | View 990 |
| 2018 | $4.7M | $3.0M | $5.3M | $52K | — | View 990 |
| 2017 | $2.9M | $2.5M | $3.7M | $166K | — | View 990 |
| 2016 | $2.5M | $2.5M | $3.1M | $89K | — | View 990 |
| 2015 | $2.5M | $2.5M | $3.2M | $36K | — | View 990 |
| 2014 | $2.1M | $1.9M | $3.3M | $188K | — | View 990 |
| 2013 | $1.8M | $1.8M | $3.2M | $250K | — | View 990 |
| 2012 | $1.3M | $1.7M | $3.0M | $59K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $8.4M, expenses of $6.5M, and assets of $18.7M (revenue +42.9% year-over-year).
- 2022: Revenue of $5.9M, expenses of $4.7M, and assets of $11.1M (revenue +56.3% year-over-year).
- 2021: Revenue of $3.8M, expenses of $3.7M, and assets of $9.8M (revenue -4.1% year-over-year).
- 2020: Revenue of $3.9M, expenses of $3.0M, and assets of $9.6M (revenue +41.8% year-over-year).
- 2019: Revenue of $2.8M, expenses of $1.1M, and assets of $9.6M (revenue -46.4% year-over-year).
- 2019: Revenue of $5.2M, expenses of $3.4M, and assets of $7.4M (revenue +9.2% year-over-year).
- 2018: Revenue of $4.7M, expenses of $3.0M, and assets of $5.3M (revenue +64.3% year-over-year).
- 2017: Revenue of $2.9M, expenses of $2.5M, and assets of $3.7M (revenue +15.1% year-over-year).
- 2016: Revenue of $2.5M, expenses of $2.5M, and assets of $3.1M (revenue +0.9% year-over-year).
- 2015: Revenue of $2.5M, expenses of $2.5M, and assets of $3.2M (revenue +18.8% year-over-year).
- 2014: Revenue of $2.1M, expenses of $1.9M, and assets of $3.3M (revenue +16.2% year-over-year).
- 2013: Revenue of $1.8M, expenses of $1.8M, and assets of $3.2M (revenue +41.8% year-over-year).
- 2012: Revenue of $1.3M, expenses of $1.7M, and assets of $3.0M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Scleroderma Research Foundation:
Data Sources and Methodology
This transparency report for Scleroderma Research Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.